Nyxoah to Participate in Bank of America 2026 Healthcare Conference

Nyxoah, a medical technology company focused on treating Obstructive Sleep Apnea, will present at the Bank of America 2026 Healthcare Conference on May 13, 2026. The presentation will occur via webcast, and the company will also engage in 1×1 meetings with institutional investors. The Genio system, Nyxoah’s lead solution, has received both European CE Mark and FDA approval for its innovative hypoglossal neurostimulation therapy.